Literature DB >> 19716544

Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome.

Mounira Habli1, Nahid Eftekhari, Emily Wiebracht, Annette Bombrys, Maram Khabbaz, Helen How, Baha Sibai.   

Abstract

OBJECTIVE: To evaluate subsequent pregnancy outcome and impact of gestational age at onset of HELLP on long-term prognosis after HELLP over an average follow-up of 5 years STUDY
DESIGN: One hundred twenty-eight patients with a history of HELLP filled out questionnaires and sent their medical records. Hemolysis, elevated liver enzymes, and low platelets data were stratified according to gestational age at onset of HELLP < or =28 weeks and >28 weeks.
RESULTS: Fifty-three patients had subsequent pregnancies with 24% complicated by HELLP and 28% by preeclampsia. During follow-up, 33% of the patients had new onset hypertension develop, 32% had depression develop, 26% had anxiety develop, and 2.4% required dialysis. There was no significant difference in long-term outcome between comparison groups.
CONCLUSION: Patients with a history of HELLP are at increased risk for preeclampsia and HELLP as well as long-term morbidities as depression and chronic hypertension. Gestational age at the onset of HELLP could be a predictor for long-term outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19716544     DOI: 10.1016/j.ajog.2009.06.033

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

Review 1.  Preeclampsia beyond pregnancy: long-term consequences for mother and child.

Authors:  Hannah R Turbeville; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-06

2.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

3.  HELLP syndrome: a diagnostic conundrum with severe complications.

Authors:  Devika Rao; Nikulkumar Kumar Chaudhari; Robert Michael Moore; Belinda Jim
Journal:  BMJ Case Rep       Date:  2016-08-17

4.  Hypertension, Anxiety, and Blood-Brain Barrier Permeability Are Increased in Postpartum Severe Preeclampsia/Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome Rats.

Authors:  Kedra Wallace; Cynthia Bean; Teylor Bowles; Shauna-Kay Spencer; Wisdom Randle; Patrick B Kyle; James Shaffery
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

5.  The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study.

Authors:  Alina M Allen; W Ray Kim; Joseph J Larson; Jordan K Rosedahl; Barbara P Yawn; Kimberly McKeon; J Eileen Hay
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-21       Impact factor: 11.382

6.  Plasma from patients with HELLP syndrome increases blood-brain barrier permeability.

Authors:  Kedra Wallace; Sarah M Tremble; Michelle Y Owens; Rachael Morris; Marilyn J Cipolla
Journal:  Reprod Sci       Date:  2014-09-06       Impact factor: 3.060

7.  Women's experiences of preeclampsia: Australian action on preeclampsia survey of women and their confidants.

Authors:  C East; K Conway; W Pollock; N Frawley; S Brennecke
Journal:  J Pregnancy       Date:  2011-03-23

8.  Depression and anxiety in pregnancy and postpartum in women with mild and severe preeclampsia.

Authors:  Zahra Abedian; Narges Soltani; Naghmeh Mokhber; Habibollah Esmaily
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Jul-Aug

Review 9.  Genetic aspects of preeclampsia and the HELLP syndrome.

Authors:  Kjell Haram; Jan Helge Mortensen; Bálint Nagy
Journal:  J Pregnancy       Date:  2014-06-02

10.  Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient.

Authors:  Muaz Abudiab; Megan L Krause; Mary E Fidler; Karl A Nath; Suzanne M Norby
Journal:  Clin Nephrol       Date:  2013-10       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.